On April 10, Brother Enterprises Holding Co.Ltd(002562) ( Brother Enterprises Holding Co.Ltd(002562) ) announced the performance forecast for the first quarter of 2022. The net profit is expected to be 100 million yuan to 130 million yuan, with a year-on-year increase of 799% ~ 1069%; The basic earnings per share is 0.09 yuan / share ~ 0.12 yuan / share, which is 0.01 yuan / share in the same period in 2021. At the end of 2021, it is worth mentioning insurance through a conference with multiple institutions.
There are two main reasons for the substantial growth of performance in the first quarter of 2022 Brother Enterprises Holding Co.Ltd(002562) said that on the one hand, in the first quarter of 2022, “the construction project with an annual output of 20000 tons of hydroquinone and 31100 tons of hydroquinone derivatives – phase I project” increased its product production capacity, output, sales volume and sales price by varying degrees compared with the same period of last year, and the project benefits were released step by step. On the other hand, affected by the rising price of raw materials, rising logistics costs, national energy conservation and emission reduction and other factors, the prices of some vitamin products and chromium salt products of the company increased by different ranges, and the gross profit margin of products increased.
Brother Enterprises Holding Co.Ltd(002562) focuses on providing customers with professional nutrition and health products and services. The announcement shows that Brother Enterprises Holding Co.Ltd(002562) was founded in 1991 and has been engaged in the fine chemical industry for more than 30 years. From leather chemicals and vitamins, new business segments and new products have been continuously developed, and two new business sectors have been developed, including flavor, fragrance and medicine. Up to now, four major industrial sectors, including vitamins, flavors, spices, pharmaceuticals and specialty chemicals, have been initially formed. Among them, vitamins, flavors and fragrances have high synergy in application areas, including feed, food, daily chemical, medicine and other related fields.
It is worth mentioning that on January 26 and 27, 2022, Brother Enterprises Holding Co.Ltd(002562) received research from a number of funds and insurance institutions through teleconference. According to the announcement, the research institutions include The People’S Insurance Company (Group) Of China Limited(601319) , Guoshou assets, Taiping assets, Nanfang fund, Galaxy fund, Tianhong fund, etc.
Brother Enterprises Holding Co.Ltd(002562) told the agency that in recent years, the company has been investing heavily in flavors and fragrances and medicine, and will strive to become a well-known new venture in the field of flavors and fragrances and medicine.
Brother Enterprises Holding Co.Ltd(002562) also announced the performance express in 2021. The operating revenue and net profit were 2.74 billion yuan and 30.129 million yuan respectively, with a year-on-year increase of 42.6% and 7.5% Brother Enterprises Holding Co.Ltd(002562) said that the production of new projects promoted the growth of sales revenue of new products, but it was still in the stage of capacity climbing and the unit production cost was high, resulting in a year-on-year decline in gross profit margin in 2021.
